XML 69 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
(Accumulated Deficit) Retained Earnings
(Accumulated Deficit) Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020     125,835,931          
Beginning balance at Dec. 31, 2020 $ 742,424 $ (200,910) $ 126 $ 883,166 $ (228,738) $ (146,819) $ 27,828 $ 5,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation $ 139,280     139,280        
Exercise of vested options (in shares) 994,456   994,456          
Exercise of vested options $ 22,706   $ 1 22,705        
Purchase of capped calls, net of taxes (64,673)     (64,673)        
Settlement of convertible senior notes, net of taxes (in shares)     985,522          
Settlement of convertible senior notes, net of taxes (423)   $ 1 (424)        
Vesting of restricted stock units, net of shares withheld (in shares)     818,442          
Vesting of restricted stock units, net of shares withheld $ (119,553)   $ 1 (119,554)        
Stock repurchase (in shares) (554,718)   (1,612,233)          
Stock repurchase $ (302,774)   $ (2)     (302,772)    
Other comprehensive income (loss) (80,965)             (80,965)
Net income (loss) 493,507         493,507    
Ending balance (in shares) at Dec. 31, 2021     127,022,118          
Ending balance at Dec. 31, 2021 628,619   $ 127 631,762   71,744   (75,014)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation (in shares) [1]     191,493          
Stock-based compensation [1] $ 248,114     248,114        
Exercise of vested options (in shares) 816,620   816,620          
Exercise of vested options $ 15,024   $ 1 15,023        
Settlement of convertible senior notes, net of taxes (in shares)     358          
Vesting of restricted stock units, net of shares withheld (in shares)     981,844          
Vesting of restricted stock units, net of shares withheld $ (79,813)   $ 1 (79,814)        
Stock repurchase (in shares) (3,958,155)   (3,958,155)          
Stock repurchase $ (425,727)   $ (4)     (425,723)    
Other comprehensive income (loss) (239,203)             (239,203)
Net income (loss) $ (694,288)         (694,288)    
Ending balance (in shares) at Dec. 31, 2022 125,054,278   125,054,278          
Ending balance at Dec. 31, 2022 $ (547,274)   $ 125 815,085   (1,048,267)   (314,217)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation (in shares) [1]     45,680          
Stock-based compensation [1] $ 300,687     300,687        
Exercise of vested options (in shares) 623,161   623,161          
Exercise of vested options $ 14,228   $ 1 14,227        
Settlement of convertible senior notes, net of taxes (in shares)     278          
Settlement of convertible senior notes, net of taxes (1)     (1)        
Vesting of restricted stock units, net of shares withheld (in shares)     1,419,337          
Vesting of restricted stock units, net of shares withheld (83,195)   $ 1 (83,196)        
Settlement of capped call (in shares)     (1,194,006)          
Settlement of capped call $ 0   $ (1) 34,224   (34,223)    
Stock repurchase (in shares) (6,879,844)   (6,879,844)          
Stock repurchase $ (582,475)   $ (7)     (582,468)    
Other comprehensive income (loss) 46,747             46,747
Net income (loss) $ 307,568         307,568    
Ending balance (in shares) at Dec. 31, 2023 119,068,884   119,068,884          
Ending balance at Dec. 31, 2023 $ (543,715)   $ 119 $ 1,081,026   $ (1,357,390)   $ (267,470)
[1] Includes the partial payment of Depop deferred consideration. See “Note 16—Stock-based Compensation” for additional information.